live attenuated influenza H1N1 vaccine (CODA-VAX H1N1) / Codagenix - LARVOL DELTA

Intramuscular CodaVax-H1N1 in Healthy Adults (clinicaltrials.gov) - P1 | N=69 | Completed | Sponsor: Codagenix, Inc | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

Intramuscular CodaVax-H1N1 in Healthy Adults (clinicaltrials.gov) - P1 | N=69 | Active, not recruiting | Sponsor: Codagenix, Inc | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

Intramuscular CodaVax-H1N1 in Healthy Adults (clinicaltrials.gov) - P1 | N=69 | Recruiting | Sponsor: Codagenix, Inc | Active, not recruiting ➔ Recruiting | N=45 ➔ 69 | Trial completion date: Oct 2022 ➔ Dec 2023 | Trial primary completion date: Oct 2022 ➔ Dec 2023

Enrollment change • Enrollment open • Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

Intramuscular CodaVax-H1N1 in Healthy Adults (clinicaltrials.gov) - P1 | N=45 | Active, not recruiting | Sponsor: Codagenix, Inc | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Respiratory Diseases

Intramuscular CodaVax-H1N1 in Healthy Adults (clinicaltrials.gov) - P1 | N=45 | Recruiting | Sponsor: Codagenix, Inc | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Respiratory Diseases